Results 111 to 120 of about 12,541,927 (431)

Risk factor analysis and predictive model construction of lean MAFLD: a cross-sectional study of a health check-up population in China

European Journal of Medical Research
Aim Cardiovascular disease morbidity and mortality rates are high in patients with metabolic dysfunction-associated fatty liver disease (MAFLD). The objective of this study was to analyze the risk factors and differences between lean MAFLD and overweight
Ruya Zhu, Caicai Xu, Suwen Jiang, Jianping Xia, Boming Wu, Sijia Zhang, Jing Zhou, Hongliang Liu, Hongshan Li, Jianjun Lou   +9 more
doaj   +1 more source

Autoimmune hepatitis and overlap syndrome among Alaska Native people: Prevalence, clinical characteristics, and remission

JGH Open, 2023
Background and Aim High autoimmune hepatitis (AIH) and overlap syndrome (OS) prevalence have been previously documented among Alaska Native people. The purpose of this project is to report changes in AIH/OS prevalence over time, clinical characteristics,
Janet M. Johnston, Brian McMahon, Lisa Townshend‐Bulson, Julia Plotnik, Paarth Jain, Meggan Judge, Wileina Rhodes, Chriss Homan   +7 more
doaj   +1 more source

The use of ultrasound in clinical setting for children affected by NAFLD. is it safe and accurate? [PDF]

, 2011
Non-alcoholic fatty liver disease (NAFLD) has become over the last decade the most common form of chronic liver disease in children and adults. Thus, establishing the diagnosis of NAFLD is of utmost importance and represents a major challenge as the ...
Alisi A, Della Corte C, Feldstein A., Monti L, Nobili V   +4 more
core   +3 more sources

Liver disease in pregnancy

Taiwanese Journal of Obstetrics and Gynecology, 2015
Deranged liver function tests are encountered in 3% of pregnancies. The potential causes are classified as those unique to and those just incidental to pregnancy. Pregnancy-related diseases are the most frequent causes of liver dysfunction during pregnancy and exhibit a trimester-specific occurrence during pregnancy.
Shashank Shekhar, Gaurav Diddi
openaire   +4 more sources

Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.

Gastroenterology, 2019
BACKGROUND & AIMS We estimated the accuracy of FibroScan vibration-controlled transient elastography controlled attenuation parameter (CAP) and liver stiffness measurement (LSMs) in assessing steatosis and fibrosis in patients with suspected nonalcoholic
P. Eddowes, M. Sasso, M. Allison, E. Tsochatzis, Q. Anstee, D. Sheridan, I. Guha, J. Cobbold, J. Deeks, V. Paradis, P. Bedossa, P. Newsome   +11 more
semanticscholar   +1 more source

Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies

PLoS Medicine, 2020
Background Non-alcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease worldwide. Many individuals have risk factors associated with NAFLD, but the majority do not develop advanced liver disease: cirrhosis, hepatic ...
H. Jarvis, D. Craig, R. Barker, G. Spiers, D. Stow, Q. Anstee, B. Hanratty   +6 more
semanticscholar   +1 more source

B cell mechanobiology in health and disease: emerging techniques and insights into therapeutic responses

FEBS Letters, EarlyView.
B cells sense external mechanical forces and convert them into biochemical signals through mechanotransduction. Understanding how malignant B cells respond to physical stimuli represents a groundbreaking area of research. This review examines the key mechano‐related molecules and pathways in B lymphocytes, highlights the most relevant techniques to ...
Marta Sampietro, Marco Cellani, Cristina Scielzo   +2 more
wiley   +1 more source

Real-world systemic sequential therapy with regorafenib for recurrent hepatocellular carcinoma: analysis of 93 cases from a single center

BMC Gastroenterology, 2023
Background Regorafenib is an oral multikinase inhibitor and became the first second-line systemic treatment for hepatocellular carcinoma (HCC) following the phase III RESORCE trial.
Qingwei Zhu, Wei Rao, Junyu Huo, Zixiang Li, Song Wang, Wensheng Qiu, Ge Guan, Yang Xin, Ning Fan, Jinzhen Cai, Liqun Wu   +10 more
doaj   +1 more source

Analysis of liver cancer detection based on image processing [PDF]

arXiv, 2022
Medical imaging is the most important tool for detecting complications in the inner body of medicine. Nowadays, with the development of image processing technology as well as changing the size of photos to higher resolution images in the field of digital medical imaging, there is an efficient and accurate system for segmenting this.
arxiv  

Development of a decision support tool to facilitate primary care management of patients with abnormal liver function tests without clinically apparent liver disease [HTA03/38/02]. Abnormal Liver Function Investigations Evaluation (ALFIE) [PDF]

, 2007
Liver function tests (LFTs) are routinely performed in primary care, and are often the gateway to further invasive and/or expensive investigations.
A Desgagne, AA Montgomery, AD Morris, AS Detsky, C Van Walraven, D Steinke, David McLernon, Douglas Steinke, DS Pratt, DT Steinke, DW Hosmer, FA Kerr, Frank M Sullivan, HC Kim, HT Sorensen, J Smith, JMM Evans, John F Dillon, KM Anderson, M Campbell, M Duh, M Futatsuka, OO Aalen, P McLone, P Roderick, P Sherwood, Paul Roderick, Peter T Donnan, PT Donnan, PT Donnan, PT Donnan, S Bellentani, Stephen Ryder, TK Gandhi, TP Almdal, William Rosenberg   +35 more
core   +7 more sources